Nigel Aj McMillan

15PUBLICATIONS
43CO-AUTHORS
Nanotoxicology, health and safetyNanomedicinePredictive and prognostic markersChemotherapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 13, 2026
What If Trojan Horse Nanoparticles Could Change the Game for HPV Gene-Targeted Therapies?

Trairong Chokwassanasakulkit, Vindya Ranasinghe, Erin Woods

|Jun 24, 2025
Extracellular Vesicle Lipids and Their Role in Delivery.

Austin Brent, Paniz Shirmast, Nigel A J McMillan

|Mar 26, 2025
How Strong Is the Link Between Merkel Cell Carcinoma and the Occurrence of Other Skin Cancer Types? A Meta-Analysis.

Trairong Chokwassanasakulkit, Nigel A J McMillan

|Jan 08, 2025
Aurora B inhibition induces hyper-polyploidy and loss of long-term proliferative potential in RB and p53 defective cells.

Shivam Vora, Saptarshi Chatterjee, Ariel Andrew

|Nov 09, 2024
Aurora B inhibitors promote RB hypophosphorylation and senescence independent of p53-dependent CDK2/4 inhibition.

Shivam Vora, Ariel Andrew, Ramyashree Prasanna Kumar

|Sep 04, 2024
Merkel Cell Polyomavirus-Pathophysiology and Treatment in the Era of Gene-Targeted Therapies.

Trairong Chokwassanasakulkit, Nigel A J McMillan

Pageof 3

Frequent Collaborators

5 joint publications

Adi Idris

3 joint publications

Trairong Chokwassanasakulkit

2 joint publications

Shivam Vora

2 joint publications

Mathew Jk Jones